What Happened?
South San Francisco, CA-based DiCE-Molecules Appointed Kevin Judice as Chief Executive Officer
About the Company
At DiCE Molecules, we design and develop innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, we are developing oral alternatives to medicines currently limited to injectable forms.
About the Person
Kevin Judice is Chief Executive Officer at DiCE Molecules. Previously, Kevin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile